LipoScience, Inc. to Present Scientific Data Highlighting the Diagnostic Capabilities of Nuclear Magnetic Resonance-Based Assays at AACC 2012 Annual Meeting

RALEIGH, N.C.--(BUSINESS WIRE)--LipoScience, Inc., an in vitro diagnostic company committed to transforming the management of heart disease, today announced at the Annual Meeting of the American Association for Clinical Chemistry at the Los Angeles Convention Center in Los Angeles, the presentation of key findings supporting the benefits of high-throughput nuclear magnetic resonance (NMR) spectroscopy analysis as a powerful analytical tool for medical diagnosis related to atherosclerosis, diabetes and oncology. Three scientific posters will be presented today during the conference that focus on this technology.